Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 0.75 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Sanofi US.

Clinical ShowCase™: Optimizing Care from Start to Finish for Patients with ESRD Requiring Renal Transplantation

Release Date: December 23, 2021
Expiration Date: December 23, 2022

Activity Overview

This online activity is designed to provide concise and easy-to-digest education in an engaging and interactive case-based format on best practices in optimizing care for patients requiring and undergoing renal transplantation. The engaging multimedia format of this program includes interactive clinical decision points with explanations at the end of the activity, and an evidence-based review supporting the teaching points covered in the cases.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Sanofi US.

Instructions for This Activity and Receiving Credit

Complete the activity (including pre- and post-activity assessments).
Answer the evaluation questions.
Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This activity is intended for transplant specialists, transplant surgeons, and nephrologists. Fellows, researchers, nurses, nurse practitioners, physician assistants, and other HCPs will be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Discuss mechanisms of renal transplant rejection that may offer targets for therapy
Formulate management plans using current and emerging therapies for desensitization of patients undergoing renal transplantation
Implement strategies to improve adherence to treatment regimens following renal transplantation

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.

Chair

Daniel C. Brennan, MD, FACP
Professor of Medicine, Johns Hopkins School of Medicine
Medical Director, The Comprehensive Transplant Center,
Johns Hopkins Hospital
Baltimore, MD

Disclosures: Grant/Research Support: Allovir, Amplyx, CareDx. Natera. Consultant: CareDx Hansa Medeor Sanofi Veloxis. Speaker's Bureau: CareDx. Sanofi, Veloxis. Other Support: Editor Transplantation and UpToDate.

Faculty

Sam Kant, MD MRCPI FASN
Clinical & Research Fellow in Transplant Nephrology,
Division of Nephrology, Comprehensive Transplant Center,
Department of Medicine,
Johns Hopkins University School of Medicine
Baltimore, Maryland

Disclosures: Other Support: Honorarium from CareDx, Medeor Therpeutics.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.